LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world’s most devastating genetic and acquired diseases. LEXEO Therapeutics’ pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine’s Department of Genetic Medicine. 

Biotechnology

Education

LEXEO Therapeutics

LEXEO Therapeutics' headquarters in New York, NY, United States

R. Nolan Townsend

José Manuel Otero

Sandi See Tai

Vivian Hwang

Ryan McHenry

Joslyn Arnon Crowe

Jenny Speer

Jenny Robertson

Eric Adler

Ronald Crystal

Paul B. McCormac

Gene Yeo

Victoria Parikh

Marianna Fontana

Iacopo Olivotto

Jeff Molkentin

Kiran Musunuru

Bernard Davitian

Paula H. J. Cholmondeley

Reinaldo Diaz

Mette Kirstine Agger

Steven Altschuler

The Clinical Development Team at LEXEO Therapeutics is responsible for designing, executing, and overseeing clinical trials to evaluate the safety and efficacy of gene therapy products. They collaborate with regulatory authorities to ensure compliance, manage clinical supplies, analyze clinical data, and generate necessary documentation to support regulatory submissions. Their goal is to advance LEXEO's therapeutic candidates through the clinical development pipeline efficiently and effectively.

Clinical Development Team

The Leadership Team at LEXEO Therapeutics is responsible for guiding the strategic direction of the company and ensuring alignment across various functions, including legal, regulatory, technical, and scientific disciplines. This team collaborates to drive innovation in gene therapy, oversee the development of the therapeutic pipeline, and navigate complex regulatory landscapes, all while fostering a culture of excellence and advancing the company's mission to combat genetic and acquired diseases.

Leadership Team

The Research and Development team at LEXEO Therapeutics is responsible for pioneering and advancing gene therapy solutions to treat severe genetic and acquired diseases. This team conducts innovative research, develops and refines processes, ensures compliance with quality standards, and manages non-clinical and bioanalytical development. They collaborate closely to translate groundbreaking scientific discoveries into viable therapeutic products.

Research and Development

The Scientific Advisory Team at LEXEO Therapeutics is responsible for providing expert guidance on the development and implementation of gene therapy strategies. This team of renowned scientists collaborates closely with the company's research and development departments to ensure the scientific integrity and efficacy of LEXEO's adeno-associated virus (AAV)-mediated therapies.

Scientific Advisory Team

The Board of Directors at LEXEO Therapeutics provides strategic oversight, governance, and direction to ensure the company effectively leverages its gene therapy pipeline to tackle genetic and acquired diseases. Comprised of experienced industry leaders, the board is responsible for making high-level policy decisions, guiding corporate strategy, and ensuring regulatory compliance to advance LEXEO’s mission.

Board of Directors

The Finance and Operations Team at LEXEO Therapeutics is responsible for managing the company's financial health and ensuring operational efficiency. This includes overseeing budget planning, financial reporting, internal controls, and strategic financial planning. The team also handles day-to-day operational activities, facilitating smooth workflow and supporting the company's mission to advance gene therapy solutions.

LEXEO Therapeutics

Org chart

Board & advisors

Teams

Clinical Development Team

Leadership Team

Research and Development

Scientific Advisory Team

Board of Directors

Finance and Operations Team

Offices

LEXEO Therapeutics

Org chart

Board & advisors

Teams

Clinical Development Team

Leadership Team

Research and Development

Scientific Advisory Team

Board of Directors

Finance and Operations Team

Offices

Related companies